Co-Amlessa

Medicinal product

(Invented) name

Co-Amlessa

Active substance (s)

tert-butilamino perindoprilis/Amlodipinas/Indapamidas

Strength

8 mg/10 mg/2,5 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C09BX01, Perindopril, amlodipine and indapamide

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2016-11-03

Date of renewal

Documents

2017-02-14_0424-01_Co_Amlessa_K.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
tert-butilamino perindoprilis	8 mg
Amlodipinas	10 mg
Indapamidas	2,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
66966	81507	1081507	lizdinė plokštelė	N30		Receptinis	LT/L/16/0424/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-10-20	Registruotas
2024-02-21	Išregistruotas
2016-11-03	Registruotas